Guardant Health (MEX:GH) Beneish M-Score: -2.73 (As of Jun. 26, 2026)


MEX:GH Guardant Health Inc MEX:GH
67 GF Score
Price MXN2,080.00
GF Value MXN879.06
! 4 Warning Signs
View Full Analysis

What is Guardant Health Beneish M-Score?

Guardant Health MEX:GH 67 Beneish M-Score is -2.73 as of Jun. 26, 2026. GuruFocus rates MEX:GH with a GF Score™ of 67/100 and a GF Value™ of MXN879.06. The stock has 4 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Guardant Health ranks better than 58.46% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.73 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Guardant Health's Beneish M-Score or its related term are showing as below:

MEX:GH' s Beneish M-Score Range Over the Past 10 Years
Min: -5.01   Med: -2.72   Max: 5.45
Current: -2.73

During the past 10 years, the highest Beneish M-Score of Guardant Health was 5.45. The lowest was -5.01. And the median was -2.72.


Guardant Health Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Guardant Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Beneish M-Score Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.69 -3.61 -2.71 -2.67 -2.68

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.43 -1.55 -1.53 -2.68 -2.73

MEX:GH vs LH, DGX, MEDP: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Guardant Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardant Health Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Guardant Health's Beneish M-Score falls into.


MEX:GH
67GF Score
Guardant Health Inc MEX:GH
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Guardant Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.818+0.528 * 0.9461+0.404 * 1.161+0.892 * 1.2827+0.115 * 1.1366
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9686+4.679 * -0.119884-0.327 * 0.9196
=-2.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was MXN2,478 Mil.
Revenue was 5439.834 + 5064.391 + 4864.808 + 4370.031 = MXN19,739 Mil.
Gross Profit was 3547.862 + 3272.968 + 3148.03 + 2841.006 = MXN12,810 Mil.
Total Current Assets was MXN24,660 Mil.
Total Assets was MXN34,538 Mil.
Property, Plant and Equipment(Net PPE) was MXN5,481 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN713 Mil.
Selling, General, & Admin. Expense(SGA) was MXN14,285 Mil.
Total Current Liabilities was MXN5,268 Mil.
Long-Term Debt & Capital Lease Obligation was MXN30,232 Mil.
Net Income was -2021.015 + -2313.624 + -1700.966 + -1881.018 = MXN-7,917 Mil.
Non Operating Income was -2.831 + -328.928 + -0.881 + -0.471 = MXN-333 Mil.
Cash Flow from Operations was -1183.36 + -474.864 + -649.623 + -1135.118 = MXN-3,443 Mil.
Total Receivables was MXN2,361 Mil.
Revenue was 4162.65 + 4208.972 + 3770.22 + 3246.963 = MXN15,389 Mil.
Gross Profit was 2633.952 + 2590.716 + 2303.509 + 1920.203 = MXN9,448 Mil.
Total Current Assets was MXN18,965 Mil.
Total Assets was MXN27,500 Mil.
Property, Plant and Equipment(Net PPE) was MXN5,520 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN831 Mil.
Selling, General, & Admin. Expense(SGA) was MXN11,497 Mil.
Total Current Liabilities was MXN4,619 Mil.
Long-Term Debt & Capital Lease Obligation was MXN26,119 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2477.765 / 19739.064) / (2361.408 / 15388.805)
=0.125526 / 0.15345
=0.818

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9448.38 / 15388.805) / (12809.866 / 19739.064)
=0.613977 / 0.64896
=0.9461

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (24659.807 + 5480.877) / 34537.868) / (1 - (18965.283 + 5519.5) / 27500.444)
=0.127315 / 0.109659
=1.161

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=19739.064 / 15388.805
=1.2827

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(830.727 / (830.727 + 5519.5)) / (712.887 / (712.887 + 5480.877))
=0.130818 / 0.115098
=1.1366

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(14285.102 / 19739.064) / (11497.319 / 15388.805)
=0.723697 / 0.747122
=0.9686

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((30232.29 + 5268.163) / 34537.868) / ((26119.332 + 4618.5) / 27500.444)
=1.02787 / 1.117721
=0.9196

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-7916.623 - -333.111 - -3442.965) / 34537.868
=-0.119884

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Guardant Health has a M-score of -2.87 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.73 mean?
Guardant Health (MEX:GH) has a Beneish M-Score of -2.73 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Guardant Health and its competitors. According to the industry distribution chart, Guardant Health ranks #81 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 41.5%.
Is Guardant Health's Beneish M-Score too high?
Guardant Health's current Beneish M-Score is -2.73. Based on the distribution chart, Guardant Health ranks #81 out of 195 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Guardant Health has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Beneish M-Score compare to LH and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Guardant Health ranks #81 out of 195 companies for Beneish M-Score. This puts Guardant Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Guardant Health and its competitors. Guardant Health's current Beneish M-Score is -2.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Guardant Health (MEX:GH) has a current Beneish M-Score of -2.73. The stock's GF Value™ is MXN879.06, compared to a current price of MXN2,080.00 — trading 136.6% above its estimated fair value. The current Beneish M-Score is -2.73. Guardant Health's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Beneish M-Score is -2.73 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,080.00 is trading 136.6% above its estimated GF Value™ of MXN879.06.

Key valuation signals for MEX:GH:

  • Beneish M-Score: -2.73
  • GF Value™: MXN879.06 vs. price of MXN2,080.00 (136.6% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
67GF Score

Get the complete analysis for MEX:GH

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,080.00
Price
MXN879.06
GF Value